This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Oct;20(8):577-81.

doi: 10.1016/j.clon.2008.07.002. Epub 2008 Aug 29.

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial

N D James, M R Sydes, N W Clarke, M D Mason, D P Dearnaley, J Anderson, R J Popert, K Sanders, R C Morgan, J Stansfeld, J Dwyer, J Masters, M K B Parmar

PMID: 18760574
DOI: 10.1016/j.clon.2008.07.002

Editorial

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial

N D James et al. Clin Oncol (R Coll Radiol). 2008 Oct.

. 2008 Oct;20(8):577-81.

doi: 10.1016/j.clon.2008.07.002. Epub 2008 Aug 29.

Authors

N D James, M R Sydes, N W Clarke, M D Mason, D P Dearnaley, J Anderson, R J Popert, K Sanders, R C Morgan, J Stansfeld, J Dwyer, J Masters, M K B Parmar

PMID: 18760574
DOI: 10.1016/j.clon.2008.07.002

No abstract available

PubMed Disclaimer

Similar articles

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J, Popert RJ, Sanders K, Morgan RC, Stansfeld J, Dwyer J, Masters J, Parmar MK. James ND, et al. BJU Int. 2009 Feb;103(4):464-9. doi: 10.1111/j.1464-410X.2008.08034.x. Epub 2008 Oct 8. BJU Int. 2009. PMID: 18990168 Clinical Trial.
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.
Sydes MR, Parmar MK, James ND, Clarke NW, Dearnaley DP, Mason MD, Morgan RC, Sanders K, Royston P. Sydes MR, et al. Trials. 2009 Jun 11;10:39. doi: 10.1186/1745-6215-10-39. Trials. 2009. PMID: 19519885 Free PMC article. Clinical Trial.
Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer.
Kattan J, Bachour M, Farhat F, El Rassy E, Assi T, Ghosn M. Kattan J, et al. Invest New Drugs. 2016 Aug;34(4):474-80. doi: 10.1007/s10637-016-0357-4. Epub 2016 May 10. Invest New Drugs. 2016. PMID: 27159981 Clinical Trial.
Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Survival Results From STAMPEDE (NCT00268476).
[No authors listed] [No authors listed] Clin Adv Hematol Oncol. 2016 Apr;14(4 Suppl 5):11-3. Clin Adv Hematol Oncol. 2016. PMID: 27167844 Review. No abstract available.
[Therapeutic options for hormone-refractory prostate cancer].
Miller K, Börgermann C, Thüroff J, Albers P, Wirth M. Miller K, et al. Urologe A. 2006 May;45(5):580, 582-5. doi: 10.1007/s00120-006-1048-0. Urologe A. 2006. PMID: 16710677 Review. German.

See all similar articles

Cited by

Online multiple hypothesis testing.
Robertson DS, Wason JMS, Ramdas A. Robertson DS, et al. Stat Sci. 2023 Nov 1;38(4):557-575. doi: 10.1214/23-STS901. Stat Sci. 2023. PMID: 38223302 Free PMC article.
Online error rate control for platform trials.
Robertson DS, Wason JMS, König F, Posch M, Jaki T. Robertson DS, et al. Stat Med. 2023 Jun 30;42(14):2475-2495. doi: 10.1002/sim.9733. Epub 2023 Apr 2. Stat Med. 2023. PMID: 37005003 Free PMC article.
Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management.
Fawaz A, Abdel-Rahman O. Fawaz A, et al. Cancer Manag Res. 2022 Dec 28;14:3589-3598. doi: 10.2147/CMAR.S340719. eCollection 2022. Cancer Manag Res. 2022. PMID: 36597515 Free PMC article. Review.
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.
Kong BY, Sim HW, Barnes EH, Nowak AK, Hovey EJ, Jeffree R, Harrup R, Parkinson J, Gan HK, Pinkham MB, Yip S, Hall M, Tu E, Carter C, Koh ES, Lwin Z, Dowling A, Simes JS, Gedye C. Kong BY, et al. BMJ Open. 2022 Sep 14;12(9):e058107. doi: 10.1136/bmjopen-2021-058107. BMJ Open. 2022. PMID: 36104135 Free PMC article.
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.
Wong C, Stavrou M, Elliott E, Gregory JM, Leigh N, Pinto AA, Williams TL, Chataway J, Swingler R, Parmar MKB, Stallard N, Weir CJ, Parker RA, Chaouch A, Hamdalla H, Ealing J, Gorrie G, Morrison I, Duncan C, Connelly P, Carod-Artal FJ, Davenport R, Reitboeck PG, Radunovic A, Srinivasan V, Preston J, Mehta AR, Leighton D, Glasmacher S, Beswick E, Williamson J, Stenson A, Weaver C, Newton J, Lyle D, Dakin R, Macleod M, Pal S, Chandran S. Wong C, et al. Brain Commun. 2021 Oct 23;3(4):fcab242. doi: 10.1093/braincomms/fcab242. eCollection 2021. Brain Commun. 2021. PMID: 34901853 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information